Overview: The Scopolamine Market is expanding steadily as healthcare providers and patients seek effective therapies for motion sickness, postoperative nausea and vomiting (PONV), and selected gastrointestinal and palliative-care applications. Scopolamine, also known as hyoscine, is an anticholinergic medicine used to prevent nausea and vomiting. The market was valued at USD 480.0 million in...